Characteristics and Reporting of Number Needed to Treat, Number Needed to Harm, and Absolute Risk Reduction in Controlled Clinical Trials, 2001-2019

被引：12

作者：

Elliott, Marissa H. ^{[1
]}

Skydel, Joshua J. ^{[2
]}

Dhruva, Sanket S. ^{[3
]}

Ross, Joseph S. ^{[4
]}

Wallach, Joshua D. ^{[5
]}

机构：

[1] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA

[2] Tufts Univ, Sch Med, Boston, MA 02111 USA

[3] Univ Calif San Francisco, Sch Med, Dept Med, San Francisco, CA USA

[4] Yale Sch Med, Dept Internal Med, New Haven, CT USA

[5] Yale Sch Publ Hlth, Dept Environm Hlth Sci, 60 Coll St,4th Floor,Room 411, New Haven, CT 06510 USA

来源：

JAMA INTERNAL MEDICINE | 2021年 / 181卷 / 02期

关键词：

D O I：

10.1001/jamainternmed.2020.4799

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This cross-sectional study assesses the trends and characteristics of absolute measure reporting in highly cited medical journals from 2001 to 2019.

引用

收藏

页码：282 / 284

页数：3

相关论文

共 50 条

[11] Misleading StatisticsThe Problems Surrounding Number Needed to Treat and Number Needed to Harm
Jane L. Hutton
Pharmaceutical Medicine, 2010, 24 (3) : 145 - 149
[12] Number needed to treat and relative risk reduction
Jain, BP
ANNALS OF INTERNAL MEDICINE, 1998, 128 (01) : 72 - 72
[13] Reduction in number to treat versus number needed to treat
Chenyang Zhang
Guosheng Yin
BMC Medical Research Methodology, 21
[14] Reduction in number to treat versus number needed to treat
Zhang, Chenyang
Yin, Guosheng
BMC MEDICAL RESEARCH METHODOLOGY, 2021, 21 (01)
[15] Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat
Johann D. Ringe
John G. Doherty
Rheumatology International, 2010, 30 : 863 - 869
[16] Absolute risk reduction in osteoporosis: assessing treatment efficacy by number needed to treat
Ringe, Johann D.
Doherty, John G.
RHEUMATOLOGY INTERNATIONAL, 2010, 30 (07) : 863 - 869
[17] NUMBER NEEDED TO TREAT - ABSOLUTE RISK REDUCTION MAY BE EASIER FOR PATIENTS TO UNDERSTAND
NORTH, D
BRITISH MEDICAL JOURNAL, 1995, 310 (6989) : 1269 - 1269
[18] Number Needed to Treat in Multiple Sclerosis Clinical Trials
Okwuokenye M.
Zhang A.
Pace A.
Peace K.E.
Neurology and Therapy, 2017, 6 (1) : 1 - 9
[19] Communicating Risks Clearly: Absolute Risk and Number Needed to Treat
Sainani, Kristin L.
PM&R, 2012, 4 (03) : 220 - 222
[20] Number-needed-to-treat and placebo-controlled trials
de Craen, AJM
Vickers, AJ
Tijssen, JGP
Kleijnen, J
LANCET, 1998, 351 (9099) : 310 - 310

← 1 2 3 4 5 →